20% OFF SCYTHENE Shop →
Back to The Combat Lab
Combat Sports ADHD Stimulants Fight Camp Weight Cutting Medications Commission

ADHD Stimulant Management in Fight Camp: How Vyvanse, Adderall, and Concerta Interact With the Weight Cut, the Appetite Curve, the Pre-Fight Warmup, and the Commission Drug Panel

· Nelson Marques, MS, RD, LD

Walk into any pro MMA locker room on a Friday weigh-in and ask a quiet question — “anyone on Adderall or Vyvanse?” — and the number of hands that go up is significantly higher than the general population rate. ADHD is diagnosed in roughly 4 to 6 percent of adults in the U.S. The combat-sports population, in the informal surveys that do exist, sits closer to the 10 to 15 percent range. Part of that is the nature of the sport — the trait cluster that makes an athlete excel in a chaotic high-stimulus environment overlaps meaningfully with the trait cluster that gets a kid diagnosed in grade school. Part of it is the pipeline — amateur wrestling programs catch a lot of the diagnosis in high school. And part of it is that stimulants genuinely help a certain kind of fighter train, study tape, cut weight, and stay sharp during the chaos of camp.

But the medication interacts with every piece of camp, and almost no fighter walks into the nutrition consult with a plan for it. The medication sits on the intake form as a single line — “Adderall 30 mg XR daily” — and the plan proceeds as if that line is not there. It is there. It changes the cut. It changes the warmup. It changes the rehydration. It changes what the state commission will allow in the sample cup on fight week.

This is the fight-camp ADHD stimulant protocol. It is the piece of the camp that almost no one writes down.

The Two Drug Families and What They Do to a Fighter

ADHD medications come in two mechanistically distinct families, and the fight-camp implications differ between them.

The amphetamine family. Adderall (mixed amphetamine salts), Adderall XR (extended-release), Vyvanse (lisdexamfetamine — a prodrug that converts to dextroamphetamine after oral absorption), Dexedrine (dextroamphetamine). These drugs increase synaptic dopamine and norepinephrine by reversing the direction of the dopamine transporter — the neurotransmitter is actively pumped out of the presynaptic terminal rather than reuptaken. The net effect at the brain is increased focus, reduced distractibility, elevated vigilance, and in a non-trivial fraction of users, mood elevation. The net effect at the body is increased heart rate, increased systolic blood pressure, suppressed appetite, elevated core temperature during exercise, increased sweat rate at a given workload, and a shift in substrate utilization toward fat oxidation at the expense of carbohydrate oxidation.

The methylphenidate family. Ritalin (immediate-release methylphenidate), Concerta (long-acting osmotic-release methylphenidate), Focalin (dexmethylphenidate), the various generics. These drugs block the dopamine transporter rather than reversing it — they allow the normally released dopamine to accumulate in the synapse rather than causing active efflux. The net effects at the brain are similar to the amphetamine family at therapeutic doses. The net effects at the body are milder: less appetite suppression, less core-temperature shift, less sweat-rate elevation, less cardiovascular load at a given dose. The duration of action is shorter on the immediate-release forms (3 to 5 hours) and matched to the amphetamine extended-release duration on Concerta (10 to 12 hours).

The practical consequence: a fighter on Vyvanse 50 mg daily and a fighter on Concerta 54 mg daily look identical on the intake form in terms of “stimulant medication, standard adult dose.” They are not identical in terms of fight-camp risk. The Vyvanse fighter needs the sweat-rate and the cardiovascular monitoring. The Concerta fighter needs it less but still needs it. Both need the appetite plan.

The Appetite Suppression Math and Why It Breaks the Cut

ADHD stimulants are appetite suppressants. The suppression peaks between 1 and 4 hours after dose, tapers across the drug’s half-life window, and generally rebounds in the evening as the medication clears. The clinical trial data in non-athlete populations documents an average 10 to 20 percent reduction in daily caloric intake in the first 4 to 8 weeks on a standard dose, with the effect attenuating across the subsequent months as the body adapts and the user learns to force-eat on a schedule rather than respond to hunger cues.

A fighter in a weight cut is already under-eating. The cut plan prescribes a specific daily caloric target — typically 60 to 80 percent of the training-phase maintenance intake during the final 4 to 6 weeks of camp, pushing down to the 40 to 50 percent range during fight week. The appetite suppression from the medication compounds with the intentional restriction, and the result is a fighter who routinely under-eats the prescribed target by 300 to 600 kcal daily without realizing it. The scale drops on the morning-weigh-in check faster than the plan predicts. The energy drops. The mood drops. The sparring performance in week 6 is worse than it should be. The fighter and the coach blame “a hard cut” — the real driver is the unaccounted-for appetite suppression stacking on the prescribed deficit.

The plan reads: force-schedule meals and snacks on a clock, independent of hunger cues, with a minimum of five eating windows per day during camp. The 30 minutes before the morning dose is the single highest-yield breakfast window — the pre-dose appetite is often the best appetite of the day. The 90-minute post-dose window is the lowest-yield window; do not program the main meal there. The evening rebound window, 10 to 12 hours after the morning dose, is often the second-highest-appetite window of the day and is where the fighter will naturally over-eat if not planned for — the fight plan uses this window for the carbohydrate-and-protein-heavy evening meal rather than letting it become an uncontrolled snack grazing session.

Fighters on a twice-daily immediate-release dose (two Adderall IR tablets, say, one at 7 a.m. and one at 12 p.m.) need to be told explicitly: eat the full breakfast before the first dose, eat a planned lunch at 11:30 a.m. before the second dose, and eat the evening meal in the 6-to-8-p.m. window as the drug is clearing. Not after. The eating happens before the dose, not around it.

Sweat Rate, Core Temperature, and the Fight-Week Dehydration Risk

The amphetamine-family medications raise core temperature during exercise by a measurable but modest amount — roughly 0.3 to 0.5 °C at a matched workload compared to the unmedicated state. They raise the sweat rate at a given workload by roughly 10 to 15 percent. They slightly blunt the thirst drive by reducing the perception of oral dryness as uncomfortable.

The compound effect on fight week — where the fighter is intentionally dehydrating in the sauna, the hot bath, and under the sweat suits — is that the body is dehydrating faster than the plan predicts. The mechanical sweat-rate testing done in week 4 or 5 of camp, if it was done on the medication during a standard training session, captures the medicated sweat rate and is fine. If it was done unmedicated — a fasted morning session before the daily dose, say — the measured sweat rate is 10 to 15 percent lower than the actual fight-week sweat rate, and the fluid replacement plan built on it will under-replace.

The fight-week protocol for the medicated fighter runs:

  • Sweat-rate test conducted on the medicated state at the training time most similar to the expected fight-week sauna session. Not pre-dose. Not fasted. The dose is the exposure the body operates under, and the test needs to capture the dose.
  • Core temperature monitored during the sauna and the hot-bath cuts — ideally with a continuous probe, at minimum with a frequent oral check — with a hard 39.0 °C ceiling that triggers immediate exit. The medicated fighter runs 0.3 to 0.5 °C hotter at matched exposure and reaches the ceiling faster.
  • The last medication dose on fight week — the day of weigh-in — is held. The fighter wakes without the morning dose, cuts the final weight, weighs in, and takes the first post-weigh-in dose only after the first liter of oral rehydration is in. The weigh-in sauna sit on an empty-stomach medicated state is the single highest-risk cardiovascular window of the camp.
  • The post-weigh-in rehydration is paced to the medication half-life. Lisdexamfetamine has a half-life of 10 to 13 hours as dextroamphetamine. Methylphenidate immediate-release runs 2 to 3 hours. Concerta releases across a 10-to-12-hour window. The fighter resuming the medication post-weigh-in needs the dose timed so that the peak sympathetic load does not land on the 4-hour post-weigh-in rehydration window where the IV-or-oral fluid load is driving a cardiac preload that the medication-driven afterload is already elevating.

Fighters who have never thought about this routinely wake on weigh-in day, take their 50 mg Vyvanse out of habit, sit in the sauna with the drug coming online, and run their heart rate 15 to 20 beats above the unmedicated baseline at the same workload, in a dehydrated state, with an elevated core temperature. This is the exposure cluster that produces the fight-week arrhythmia and the fight-week hospital visit. The intervention is the dose hold. Not reducing the dose. Holding it.

The Caffeine Stack on the Warmup

The pre-fight warmup is the single highest sympathetic-load window of the camp. The fighter is 30 minutes from a professional fight, the adrenaline is at its lifetime peak, the pre-workout formula with 300 mg of caffeine has gone down 45 minutes earlier, and the heart rate at rest is reading 110 beats per minute before the mitts come out.

Add a 50 mg Vyvanse dose that was taken at 10 a.m. for a 9 p.m. fight, and the dextroamphetamine metabolite is at its peak serum concentration in the exact window the fighter is warming up. The blood pressure is elevated 10 to 15 mm Hg systolic above the unmedicated state. The cardiac output is elevated 15 to 20 percent above the unmedicated state. The caffeine on top adds another 15 mm Hg systolic. The combined cardiovascular load is well into the range the general-population cardiology literature flags as high-risk for a 25-to-35-year-old male.

The fighter has no symptoms. The training-adapted cardiovascular system tolerates the load. But the margin against an arrhythmia, against a vasospasm, against the rare but documented amphetamine-plus-exercise cardiac events is narrower than most fighters realize.

The warmup-stack protocol for the medicated fighter runs:

  • The pre-fight caffeine dose is cut in half. If the fighter normally uses 300 mg of caffeine pre-training, the fight-day dose is 150 mg. The medication supplies the focus and the vigilance; the caffeine adds marginal benefit and large cardiovascular cost on top.
  • No pre-workout formula containing synephrine, yohimbine, higenamine, or any other sympathomimetic stimulant on fight week. The stacked-sympathomimetic cardiovascular events are overwhelmingly driven by the stimulant stack rather than any single drug.
  • The fight-day medication dose is timed to peak well before the warmup, not during. A noon dose of Vyvanse for a 9 p.m. fight puts the peak dextroamphetamine serum concentration at approximately 4 p.m. and the sympathetic load tapering through the 6-to-9-p.m. window. A 4 p.m. dose puts the peak at 8 p.m. and stacks directly on the warmup. Earlier is safer. The fighter and the dietitian plan the fight-day dose around the warmup, not around breakfast.

The Athletic Commission Drug Panel and the Therapeutic Use Exemption

Every major state athletic commission (California, Nevada, New York, Texas, Florida, and most others) runs a pre-fight and in-some-cases post-fight urine sample. The panel varies by commission but reliably includes amphetamines, methylphenidate, and a broader stimulant screen. A positive amphetamine or methylphenidate test without an approved therapeutic use exemption (TUE) on file is a positive doping result in most commission jurisdictions and will overturn the fight result, generate a suspension, and in the WADA-code-aligned commissions (increasingly the standard) produce a 2-to-4-year ban on first offense.

The Vyvanse fighter who has been on the medication for six years, who has a legitimate ADHD diagnosis, who has the prescription on record with his primary-care physician — that fighter still tests positive on the commission panel and still faces the sanction if the TUE is not filed in advance.

The TUE process varies by commission but generally runs:

  • File the TUE application 60 days before the fight date. Most commissions require pre-fight approval, not retroactive.
  • Submit the complete diagnosis documentation — the original diagnostic evaluation (often from childhood or adolescence), the current prescribing physician’s notes, the current medication list, and the justification for the medication as a continuing medical necessity.
  • Document that non-stimulant alternatives have been tried and have been inadequate. Commissions reasonably ask whether the Strattera or the Wellbutrin or the Intuniv alternatives have been tried before approving a performance-plausibly-enhancing stimulant. Most adult ADHD patients have a documented trial history on at least one non-stimulant, and the prescribing physician’s chart will carry it.
  • Expect approval for the therapeutic dose, not above. A TUE for Vyvanse 30 mg will not cover a fight-day urine sample reflecting a 70 mg dose. The fighter who has been prescribed 30 mg but takes 50 or 70 mg because “the 30 mg does not work anymore” is out of compliance with the TUE regardless of the underlying diagnosis.
  • File the renewal annually. TUEs expire. The fighter who filed in 2023, fought under the approved TUE in 2024, and assumes the 2025 and 2026 fights are covered is wrong — the TUE needs to be renewed on the commission’s documented schedule, typically annually.

Fighters who have been training on the medication for years without issue often discover the TUE requirement the week before their first professional fight or, worse, after a positive pre-fight sample. The intervention is a clean paperwork check at the start of camp: medication, diagnosis documentation, prescribing-physician contact, and the specific commission’s TUE application form filled and submitted.

The Alternative Path — Coming Off for Camp

Some fighters elect to come off the medication for the final 6 to 12 weeks of camp rather than file the TUE or rather than manage the stack. The decision is reasonable and depends on three variables.

The severity of the underlying ADHD. The fighter who is highly dependent on the medication for daily functioning — can’t study tape without it, can’t follow the technical coaching in an evening sparring session without it, can’t maintain the sleep-and-meal schedule without it — will perform worse off the medication and should keep the TUE path. The fighter whose ADHD is milder and who has learned coping strategies will often do fine for 8 to 12 weeks off the drug and can come off cleanly.

The commission requirement. A commission that requires 60-day pre-fight paperwork essentially forces the decision at camp start. The TUE path is a commitment made 8 to 12 weeks out. The come-off path is also a commitment — the amphetamine family in particular should be tapered rather than stopped cold, and the taper runs 4 to 6 weeks for a standard dose.

The prescribing physician. The physician who prescribed the medication needs to know the fighter is coming off for camp. Do not come off without talking to them. The taper schedule, the alternative medication bridge (bupropion or atomoxetine can cover a chunk of the functional deficit without the amphetamine stimulant signal), and the restart schedule post-fight all need to be planned.

The fighter who comes off the medication for camp needs the appetite plan rewritten (the natural appetite rebounds and the cut needs to account for that), the training-load plan rewritten (the recovery capacity shifts off the medication), and the fight-day warmup rewritten (the natural pre-fight focus is different without the drug and may require a smaller caffeine dose or a different pre-fight routine).

The Camp-Start Checklist

Every fighter on an ADHD stimulant at camp start works through:

  • Drug family and dose. Amphetamine vs methylphenidate, standard vs extended-release, total daily milligrams.
  • Prescribing physician contact. Name, practice, phone number, and the last visit date. Medications need prescription renewals across a 12-week camp, and the fighter needs to know when to refill.
  • Commission TUE status. Filed, approved, expired, never filed. If not filed, file today.
  • Fight-week dose plan. What time the morning dose goes in, what time the evening dose goes in (if applicable), what time the weigh-in-day dose is held, what time the post-weigh-in dose resumes.
  • Fight-day dose plan. What time the fight-day dose goes in to put the peak well before the warmup.
  • Sweat-rate test on the medicated state. Not pre-dose, not fasted.
  • Pre-workout stimulant stack reduction. Caffeine halved, no synephrine, no yohimbine, no higenamine.
  • Meal plan anchored to pre-dose windows, not post-dose. The high-appetite windows carry the main meals.

This piece of camp does not take long. It takes an hour in the week-one consult, a mid-camp check at week 6, and a fight-week review at week 11. It does not change the cut. It does not change the fueling. It changes the risk floor of the camp from the single largely-unaccounted-for medication on the intake form to a managed exposure with a plan around it.

The medication is there. Train with it in view. Cut with it in view. Fight with it in view. And file the paperwork.

20% OFF Scythene — for Academy students & Calsanova members

Learn more →